Literature DB >> 23408682

Human endogenous retrovirus-K18 superantigen expression and human herpesvirus-6 and human herpesvirus-7 viral loads in chronic fatigue patients.

Brendan Oakes1, Matthias Hoagland-Henefield, Anthony L Komaroff, Jessica L Erickson, Brigitte T Huber.   

Abstract

BACKGROUND: Chronic fatigue syndrome (CFS) is a complex, heterogeneous disease characterized by debilitating fatigue that is not improved with bed rest and worsens after physical activity or mental exertion. Despite extensive research into a cause of CFS, no definitive etiology has been determined; however, a large percentage of CFS patients note an acute infectious event that triggers their fatigue.
METHODS: Blood and saliva were collected from 39 CFS cases and 9 healthy control subjects. Peripheral blood mononuclear cells (PBMCs) were tested for human endogenous retrovirus-K18 (HERV-K18) env transcripts using a TaqMan quantitative polymerase chain reaction (qPCR). In addition, viral copy number of human herpesvirus-6 (HHV-6) and human herpesvirus-7 (HHV-7) were measured in both saliva and PBMCs using TaqMan qPCRs. Transcript levels and viral copy number were compared to patient CFS symptom severity.
RESULTS: HERV-K18 env transcripts were not significantly different between healthy control subjects and CFS patients. Also, HERV-K18 env transcripts did not correlate with HHV-6 viral copy number or HHV-7 viral copy number in either PBMCs or saliva. HHV-6 viral copy number and HHV-7 viral copy number in both PBMCs and saliva were not significantly different between healthy control subjects and CFS patients. HERV-K18 env transcripts, HHV-6 viral copy number, and HHV-7 viral copy number did not correlate with CFS symptom severity.
CONCLUSIONS: We fail to demonstrate a difference in HERV-K18 env transcripts, HHV-6 viral copy number, and HHV-7 viral copy number between CFS patients and healthy controls. Our data do not support the hypothesis of reactivation of HHV-6 or HHV-7 in CFS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23408682     DOI: 10.1093/cid/cit086

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  7 in total

1.  Human Herpesvirus 6 Infection and Risk of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Sayed-Hamidreza Mozhgani; Farid Rajabi; Mohsen Qurbani; Yousef Erfani; Somayeh Yaslianifard; Azam Moosavi; Kiomars Pourrostami; Ali Baradaran Bagheri; Alireza Soleimani; Farida Behzadian; Mahshid Safavi; Farhad Rezaei
Journal:  Intervirology       Date:  2021-06-23       Impact factor: 1.763

2.  A contaminant-free assessment of Endogenous Retroviral RNA in human plasma.

Authors:  Timokratis Karamitros; Dimitrios Paraskevis; Angelos Hatzakis; Mina Psichogiou; Ioannis Elefsiniotis; Tara Hurst; Anna-Maria Geretti; Apostolos Beloukas; John Frater; Paul Klenerman; Aris Katzourakis; Gkikas Magiorkinis
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

Review 3.  Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.

Authors:  Joseph Ongrádi; Dharam V Ablashi; Tetsushi Yoshikawa; Balázs Stercz; Masao Ogata
Journal:  J Neurovirol       Date:  2016-08-18       Impact factor: 2.643

4.  HERV-K and HERV-W transcriptional activity in myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  Lucas S Rodrigues; Luiz H da Silva Nali; Cibele O D Leal; Ester C Sabino; Eliana M Lacerda; Caroline C Kingdon; Luis Nacul; Camila M Romano
Journal:  Auto Immun Highlights       Date:  2019-11-15

Review 5.  How Retroviruses and Retrotransposons in Our Genome May Contribute to Autoimmunity in Rheumatological Conditions.

Authors:  Tomas Mustelin; Kennedy C Ukadike
Journal:  Front Immunol       Date:  2020-11-13       Impact factor: 7.561

6.  Commentary: Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

Authors:  Maria Eugenia Ariza
Journal:  Front Immunol       Date:  2020-07-23       Impact factor: 7.561

Review 7.  Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Authors:  Santa Rasa; Zaiga Nora-Krukle; Nina Henning; Eva Eliassen; Evelina Shikova; Thomas Harrer; Carmen Scheibenbogen; Modra Murovska; Bhupesh K Prusty
Journal:  J Transl Med       Date:  2018-10-01       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.